Laparoscopic transperitoneal pudendal nerve and artery release for pudendal entrapment syndrome

  • PDF / 983,774 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 82 Downloads / 292 Views

DOWNLOAD

REPORT


and Other Interventional Techniques

Laparoscopic transperitoneal pudendal nerve and artery release for pudendal entrapment syndrome Renaud Bollens1,2 · Georges Mjaess3   · Julien Sarkis3 · Anthony Kallas Chemaly3 · Elie Nemr3 · Karim Daher4 · Albert Semaan3 · Josselin Abi Chebel3 · Fabienne Absil5 · Fouad Aoun3,6 Received: 25 June 2020 / Accepted: 3 October 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Introduction  Pudendal nerve and artery entrapment is an underdiagnosed pathology responsible of several urinary, sexual and anorectal complaints. The aim of our study was to evaluate safety and feasibility of laparoscopic transperitoneal pudendal nerve and artery release in a large retrospective cohort of patients with pudendal nerve entrapment syndrome with both a short and long-term follow-up. Technical details and outcomes are also reported. Methods  A series of 235 patients with pudendal syndrome underwent laparoscopic transperitoneal pudendal canal release between June 2015 and February 2020. Operative data were recorded prospectively for all patients. A complete history, pain visual analog scale (VAS) for perineodynia, and three scores evaluating the main symptoms (USP, IIEF-5, PAC-SYM) were obtained before and at least 24 months after surgery for 32 patients only. Post-operative complications were also evaluated using Clavien-Dindo classification at regular interval. Results  The mean operating time per side was 33.9 ± 6.8 min and the average hospital stay was 1.9 ± 0.3 days. Blood loss was 20 cc ± 10 cc with no patients needing transfusion. The only significant per-operative complication was hemorrhage (600 ml) in one patient induced by a pudendal artery laceration, successfully treated by laparoscopic suturing. Post-operative complications were noted in 18.7% of patients with no serious Clavien-Dindo complications. Perineodynia VAS dropped from 6.8 ± 0.9 to 2.2 ± 1.8 after surgery (p